drugset / Trial / NCT03373591

Liposomal Bupivacaine in Bariatric Surgery

NCT03373591 ↗

Phase 2 Completed 219 enrolled Montefiore Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to perform a randomized controlled trial for patients undergoing bariatric surgery, comparing the need for opiates with and without administration of a transversus abdominis plane (TAP) block using the long acting local anesthetic, liposomal bupivacaine (Exparel®). From this study, the investigators will assess whether use of long acting local anesthetic can reduce the need for opiates in the bariatric population.

Timeline

Start
2018-01-30
Primary completion
2018-06-30
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 20 ml Other
Comparator Bupivacaine Other / unclassified 50 ml Other

Indications

No indication recorded.